Antisense strategies in neurobiology (Q41092478)

26 September 2017

1 reference

title

Antisense strategies in neurobiology (English)

1 reference

antisense oligonucleotide

26 September 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9246677

10 November 2024

B. Weiss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9246677

10 November 2024

G. Davidkova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9246677

10 November 2024

S. P. Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9246677

10 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9246677

10 November 2024

publication date

1 September 1997

1 reference

26 September 2017

September 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9246677

full work available at URL

10 November 2024

https://api.elsevier.com/content/article/PII:S0197018696001052?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

https://api.elsevier.com/content/article/PII:S0197018696001052?httpAccept=text/plain

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Neurochemistry International

10 November 2024

published in

1 reference

26 September 2017

1 reference

26 September 2017

1 reference

26 September 2017

page(s)

321-348

1 reference

A BDNF autocrine loop in adult sensory neurons prevents cell death.

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Intracerebroventricular treatment with an antisense oligodeoxynucleotide to kappa-opioid receptors inhibited kappa-agonist-induced analgesia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Pharmacokinetics of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense knockouts: molecular scalpels for the dissection of signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

A decrease in angiotensin receptor binding in rat brain nuclei by antisense oligonucleotides to the angiotensin AT1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense proenkephalin cDNA transfection decreases opioid binding in NG 108-15 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Uptake by macrophages of a biotinylated oligo-alpha-deoxythymidylate by using mannosylated streptavidin

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Identification of a family of muscarinic acetylcholine receptor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

New perspectives on cocaine addiction: recent findings from animal research.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Cell membranes as barriers for antisense constructions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

The current status of the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Opioid peptide receptor studies. 1. Identification of a novel delta-opioid receptor binding site in rat brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

An antisense oligodeoxynucleotide to mu-opioid receptors inhibits mu-opioid receptor agonist-induced analgesia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

The application of antisense oligonucleotide technology to the brain: some pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Ontogenetic development of calmodulin mRNA in rat brain using in situ hybridization histochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Molecular biology of the dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligodeoxynucleotides as antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Therapeutic Applications of Oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Reduced level of calmodulin in PC12 cells induced by stable expression of calmodulin antisense RNA inhibits cell proliferation and induces neurite outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

The calmodulin hypothesis of neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

New Drugs: Antisense Agents in Cancer Research and Therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

In vivo antisense inhibition of prodynorphin expression in rat striatum: dose-dependence and sequence specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Inhibition of c-Fos Protein Expression in Rat Spinal Cord by Antisense Oligodeoxynucleotide Superfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Recent advances in the molecular biology of dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

1 reference

7 January 2021

Antisense has growing pains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Involvement of mature tau isoforms in the stabilization of neurites in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Rationally designed analogues of tamoxifen with improved calmodulin antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense as an explanatory, experimental and therapeutic tool for psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Specific regulation of gene expression by antisense, sense and antigene nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Inhibition of interferon-gamma-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense-non-specific effects

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of fos and produces a behavioral effect

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

mu- and delta-opioid receptor antisense oligodeoxynucleotides antagonize morphine-induced growth hormone secretion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense GAP-43 inhibits the evoked release of dopamine from PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Inhibition of nerve growth factor-induced B-50/GAP-43 expression by antisense oligomers interferes with neurite outgrowth of PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Gephyrin antisense oligonucleotides prevent glycine receptor clustering in spinal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Cell delivery and mechanisms of action of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Modulation of the PC12 cell response to nerve growth factor by antisense oligonucleotide to amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Applications of antisense oligodeoxynucleotides in virology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Infusion of antisense oligodeoxynucleotides to the oxytocin receptor in the ventromedial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor binding in the female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Intracerebral administration of antisense oligodeoxynucleotides to GAD65 and GAD67 mRNAs modulate reproductive behavior in the female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligonucleotide inhibition of tryptophan hydroxylase activity in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Calcium, calmodulin and cell cycle regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense vasopressin oligonucleotides: uptake, turnover, distribution, toxicity and behavioral effects

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Current concepts in antisense drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Central oxytocin mediates stress-induced tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Stimulation of spinal delta-opioid receptors in mice selectively enhances the attenuation of delta-opioid receptor-mediated antinociception by antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense inhibition of gene expression: a tool for studying the role of NMYC in the growth and differentiation of neuroectoderm-derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Adenovirus vectors enter the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Dopamine D3 receptor antisense influences dopamine synthesis in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Dopamine receptors: molecular structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Modulation of substance P/neurokinin-1 receptor in human astrocytoma cells by antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

The thyroliberin receptor interacts directly with a stimulatory guanine-nucleotide-binding protein in the activation of adenylyl cyclase in GH3 rat pituitary tumour cells. Evidence obtained by the use of antisense RNA inhibition and immunoblocking o

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligonucleotide inhibition of gene expression: application to endocrine systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

ANTISENSE oligonucleotides: a new tool in neuroscience

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Inhibition of Glutamate-induced Neurotoxicity by a Tau Antisense Oligonucleotide in Primary Culture of Rat Cerebellar Granule Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligonucleotide blocks progesterone-induced lordosis behavior in ovariectomized rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

G-protein antisense oligodeoxyribonucleotides and mu-opioid supraspinal antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Gene therapy in the central nervous system: direct versus indirect gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Anatomical localization of calmodulin mRNA in the rat brain with cloned cDNA and synthetic oligonucleotide probes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Intracerebroventricular administration of AT1 receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

The involvement of nucleus accumbens dopamine in appetitive and aversive motivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Opposite functions of jun-B and c-jun in growth regulation and neuronal differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

An approach for new anticancer drugs: oncogene-targeted antisense DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Transient requirement for vimentin in neuritogenesis: intracellular delivery of anti-vimentin antibodies and antisense oligonucleotides inhibit neurite initiation but not elongation of existing neurites in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Vasopressin antisense oligonucleotide induces temporary diabetes insipidus in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Ventral tegmental area (VTA) injections of tyrosine hydroxylase phosphorothioate antisense oligonucleotide suppress operant behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligonucleotide to c-fos induces ipsilateral rotational behaviour to d-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Pretreatment with antisense oligodeoxynucleotides directed against the NMDA-R1 receptor enhances survival and behavioral recovery following traumatic brain injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense to thyrotropin releasing hormone receptor reduces arterial blood pressure in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

The inhibition of neurite outgrowth in PC12 cells by tubulin antisense oligodeoxyribonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Sequence-specific impairment of learning by c-jun antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Neurite outgrowth in peripherin-depleted PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligonucleotides: a new therapeutic principle

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligodeoxynucleotide to the CCKB receptor produces naltrindole- and [Leu5]enkephalin antiserum-sensitive enhancement of morphine antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligonucleotide strategies in neuropharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense strategies in dopamine receptor pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense inhibition of hypertension in the spontaneously hypertensive rat

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Brain dopamine and reward

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Uptake of antisense oligonucleotides and functional block of acetylcholine receptor subunit gene expression in primary embryonic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

New approaches to molecular therapy of brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Reduction in muscarinic receptors by antisense oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Uptake and distribution of fluorescein-labeled D2 dopamine receptor antisense oligodeoxynucleotide in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Regional distribution of calmodulin activity in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Brief overview of control of genetic expression by antisense oligonucleotides and in vivo applications. Prospects for neurobiology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2896%2900105-2

7 January 2021

Chronic neuroleptic treatment and dopamine receptor regulation

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Pharmacokinetic properties of several novel oligonucleotide analogs in mice

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Antisense strategies in leukemia

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

A specific antisense oligodeoxynucleotide to mRNAs encoding receptors with seven transmembrane spanning regions decreases muscarinic m2 and gamma-aminobutyric acidB receptors in rat cerebellar granule cells

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Liposomes as a drug delivery system for antisense oligonucleotides

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Treatment with antisense oligodeoxynucleotide to a conserved sequence of opioid receptors inhibits antinociceptive effects of delta subtype selective ligands

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Retrovirus-mediated transfer of an angiotensin type I receptor (AT1-R) antisense sequence decreases AT1-Rs and angiotensin II action in astroglial and neuronal cells in primary cultures from the brain

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Delivery of angiotensin II type 1 receptor antisense inhibits angiotensin action in neurons from hypertensive rat brain

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors

10 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Applications of antisense oligonucleotides in oncology

10 November 2024

109

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia

10 November 2024

117

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Basic mechanisms of motor fluctuations

10 November 2024

124

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Progress in the medicinal chemistry of dopaminergic agents

10 November 2024

128

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Brain dopamine receptors in schizophrenia and tardive dyskinesia

10 November 2024

132

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine

10 November 2024

134

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system

10 November 2024

141

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

c-fos antisense in rostral ventral medulla reduces arterial blood pressure

10 November 2024

146

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Increased content of calmodulin in human leukemia cells

10 November 2024

149

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I

10 November 2024

154

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Specificity of antisense oligonucleotides in vivo

10 November 2024

176

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine

10 November 2024

183

1 reference

https://api.crossref.org/works/10.1016/S0197-0186(96)00105-2

10 November 2024

Identifiers

1 reference

26 September 2017

1 reference